SCHEMBL24253547

SCHEMBL24253547

Cc1cn2cccc2cc1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.38
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
G6PD P11413 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
CCR6 P51684 1/20 0.37
HIF1A Q16665 1/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8404410 0.81 ALOX15 (0.42) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL24248985 0.76 LMNA (0.40) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL25065095 0.72 ALOX15 (0.34) ALOX15ALDH1A1KDM4EMAPTNPC1
SCHEMBL24874239 0.72 GABRA1 (0.39) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL321553 0.68 ALOX15 (0.48) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL24874256 0.67 IDO1 (0.36) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL4566860 0.66 ALOX15 (0.50) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL4566858 0.66 ALOX15 (0.50) ALOX15ALDH1A1KDM4EMAPTHPGD
SCHEMBL275633 0.66 ALOX15 (0.50) ALOX15ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL276216 0.66 ALOX15 (0.50) ALOX15ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-02-23 US disclosed
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 ALOX15 677/4885ALDH1A1 3964/4885KDM4E 2544/4885
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 ALOX15 677/4885ALDH1A1 3964/4885KDM4E 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.